Admission of the Second Tranche Placing Shares

LONDON and NEW YORK - 1 July 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) confirms that, further to the announcements made on 12 March 2024 and 25 April 2024, the Second Resale Registration Statement has become effective on 28 June 2024 and accordingly an application has been made to London Stock Exchange plc for the admission to trading of the Second Tranche Placing Shares. The Second Tranche Placing Shares, being 26,815,841 shares, were issued on 24 April 2024 and will be admitted to trading on AIM on 2 July 2024 at 8am.

The Second Tranche Placing Shares have been credited as fully paid and rank pari passu in all respects with the Company's existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue.

The Company's total issued share capital remains at 154,368,191 Ordinary Shares of £0.0025 each in the capital of the Company and the shareholders can use this number as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Capitalised terms used but not defined in this announcement have the meanings given to them in the announcement dated 12 March 2024, unless the context provides otherwise.